Fig. 1From: Endoscopic central airway recanalization to enable first line pembrolizumab treatment in a PD-L1 strongly positive non-small cell lung cancer: a case reportChest x-rays showed pulmonary atelectasis involvement due to the cancer progression associated with four recurrent episodes of lung infectionBack to article page